{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:13:58Z","timestamp":1791123238427,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015629","name":"Chinook Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK109563"],"award-info":[{"award-number":["R01DK109563"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK124895"],"award-info":[{"award-number":["R01DK124895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007183","name":"University of California, Santa Barbara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010827"],"award-info":[{"award-number":["W81XWH2010827"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xcrm.2025.102335","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T15:50:09Z","timestamp":1757087409000},"page":"102335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a cyst-targeted therapy for polycystic kidney disease using an antagonistic dimeric IgA monoclonal antibody against cMET"],"prefix":"10.1016","volume":"6","author":[{"given":"Margaret F.","family":"Schimmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan C.","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison K.","family":"Spindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sage A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin E.","family":"Cornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-5561","authenticated-orcid":false,"given":"Thomas","family":"Weimbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102335_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.xcrm.2025.102335_bib2","doi-asserted-by":"crossref","first-page":"F86","DOI":"10.1152\/ajprenal.00346.2017","article-title":"Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease","volume":"315","author":"Olsan","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.xcrm.2025.102335_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5414\/CN109927Letter","article-title":"Doubts about the efficacy of tolvaptan for polycystic kidney disease","volume":"93","author":"Anderson","year":"2020","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.xcrm.2025.102335_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ndt\/gfy297","article-title":"Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease","volume":"34","author":"Torres","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.xcrm.2025.102335_bib5","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfy089","article-title":"Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease","volume":"11","author":"Weimbs","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.xcrm.2025.102335_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1241145","article-title":"Antibody therapeutics in cancer","volume":"341","author":"Sliwkowski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102335_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/glycob\/cwy043","article-title":"Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics","volume":"28","author":"Dalziel","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.xcrm.2025.102335_bib8","doi-asserted-by":"crossref","first-page":"15679","DOI":"10.1074\/jbc.M114.607929","article-title":"Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease","volume":"290","author":"Olsan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102335_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1101\/SQB.1995.060.01.083","article-title":"Regulation of protein traffic in polarized epithelial cells: the polymeric immunoglobulin receptor model","volume":"60","author":"Mostov","year":"1995","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v10050237","article-title":"The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity","volume":"10","author":"Turula","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102335_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56098","article-title":"The structures of Secretory and dimeric Immunoglobulin A","volume":"9","author":"Kumar Bharathkar","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2025.102335_bib12","doi-asserted-by":"crossref","first-page":"18067","DOI":"10.1073\/pnas.1111966108","article-title":"Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease","volume":"108","author":"Olsan","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102335_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf093","article-title":"Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease","volume":"18","author":"Burgmaier","year":"2025","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.xcrm.2025.102335_bib14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ajpath.2019.06.015","article-title":"Localization and Regulation of Polymeric Ig Receptor in Healthy and Diseased Human Kidney","volume":"189","author":"Krawczyk","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2025.102335_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/19420862.2019.1622940","article-title":"Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice","volume":"11","author":"Lombana","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102335_bib16","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.166.6.3688","article-title":"A Mucosal IgA-Mediated Excretory Immune System In Vivo1","volume":"166","author":"Robinson","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840090518","article-title":"The liver and IgA: immunological, cell biological and clinical implications","volume":"9","author":"Brown","year":"1989","journal-title":"Hepatol. Baltim Md"},{"key":"10.1016\/j.xcrm.2025.102335_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-3083.1990.tb03199.x","article-title":"Site of Catabolism of Autologous and Heterologous IgA in Non-Human Primates","volume":"32","author":"Moldoveanu","year":"1990","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(94)92344-2","article-title":"Mediation of renal cyst formation by hepatocyte growth factor","volume":"344","author":"Horie","year":"1994","journal-title":"Lancet Lond. Engl"},{"key":"10.1016\/j.xcrm.2025.102335_bib20","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI41531","article-title":"Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease","volume":"120","author":"Qin","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102335_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000509419","article-title":"Diverse Receptor Tyrosine Kinase Phosphorylation in Urine-Derived Tubular Epithelial Cells from Autosomal Dominant Polycystic Kidney Disease Patients","volume":"144","author":"Ikeda","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.xcrm.2025.102335_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091968","article-title":"Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain","volume":"18","author":"Park","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102335_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/biomedicines2040359","article-title":"Monoclonal Antibodies against the MET\/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy","volume":"2","author":"Prat","year":"2014","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2025.102335_bib24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/db11-1578","article-title":"A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control","volume":"61","author":"Bhaskar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2025.102335_bib25","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1091\/mbc.11.9.3045","article-title":"Intracellular Redirection of Plasma Membrane Trafficking after Loss of Epithelial Cell Polarity","volume":"11","author":"Low","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.xcrm.2025.102335_bib26","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102335_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102335_bib28","doi-asserted-by":"crossref","first-page":"F352","DOI":"10.1152\/ajprenal.00205.2023","article-title":"A combination of \u03b2-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease","volume":"326","author":"Torres","year":"2024","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.xcrm.2025.102335_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines3010071","article-title":"HGF\/c-MET Axis in Tumor Microenvironment and Metastasis Formation","volume":"3","author":"Spina","year":"2015","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2025.102335_bib30","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3748\/wjg.v24.i33.3695","article-title":"Updates on the hepatocyte growth factor\/c-Met axis in hepatocellular carcinoma and its therapeutic implications","volume":"24","author":"Garc\u00eda-Vilas","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2025.102335_bib31","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1073\/pnas.0508156103","article-title":"Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity","volume":"103","author":"Petrelli","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102335_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109648","article-title":"Molecular pathways involved in injury-repair and ADPKD progression","volume":"72","author":"Formica","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.xcrm.2025.102335_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejcb.2010.01.002","article-title":"Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion","volume":"89","author":"Fu","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102335_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00704","article-title":"Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG","volume":"10","author":"Brandsma","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2021.02.013","article-title":"Efficient production of recombinant secretory IgA against Clostridium difficile toxins in CHO-K1 cells","volume":"331","author":"Bhaskara","year":"2021","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102335_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/0008-5472.CAN-15-1232","article-title":"An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo","volume":"76","author":"Lohse","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102335_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/19420862.2015.1106658","article-title":"Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting","volume":"8","author":"Meyer","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102335_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molimm.2015.09.005","article-title":"IgA as therapeutic antibody","volume":"68","author":"Leusen","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166821","article-title":"Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs","volume":"14","author":"von Gunten","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2025.102335_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/antib8040057","article-title":"IgA: Structure, Function, and Developability","volume":"8","author":"de Sousa-Pereira","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.xcrm.2025.102335_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/19420862.2015.1102812","article-title":"A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA","volume":"8","author":"Rouwendal","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102335_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130536","article-title":"Each N-glycan on human IgA and J-chain uniquely affects oligomericity and stability","volume":"1868","author":"Pan","year":"2024","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"10.1016\/j.xcrm.2025.102335_bib45","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.191.12.2171","article-title":"The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes","volume":"191","author":"Rifai","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102335_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97844","article-title":"Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti\u2013Pseudomonas aeruginosa antibodies","volume":"3","author":"Borrok","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102335_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1708030","article-title":"Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologics","volume":"12","author":"Maruthachalam","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102335_bib48","first-page":"157","article-title":"An IgA mimicry of IgG that binds Polymeric Immunoglobulin Receptor for mucosa transcytosis","volume":"3","author":"Mao","year":"2020","journal-title":"Antib. Ther."},{"key":"10.1016\/j.xcrm.2025.102335_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026299","article-title":"Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH","volume":"6","author":"Emmerson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102335_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/19420862.2017.1281505","article-title":"Enhancement of antibody functions through Fc multiplications","volume":"9","author":"Wang","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2025.102335_bib51","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.167.9.5185","article-title":"The J Chain Is Essential for Polymeric Ig Receptor-Mediated Epithelial Transport of IgA","volume":"167","author":"Johansen","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2016.06.011","article-title":"Unraveling the immunopathogenesis of glomerular disease","volume":"169","author":"Dickinson","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102335_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.kint.2023.09.024","article-title":"Exploiting the neonatal crystallizable fragment receptor to treat kidney disease","volume":"105","author":"Dylewski","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.xcrm.2025.102335_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-0716-1008-4_9","article-title":"Generating a Podocyte-Specific FcRn Knockout Mouse","volume":"2224","author":"Blaine","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.200809122","article-title":"The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity","volume":"185","author":"Tzaban","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102335_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.17","article-title":"Progress of antibody-based inhibitors of the HGF\u2013cMET axis in cancer therapy","volume":"49","author":"Kim","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102335_bib58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biocel.2014.01.009","article-title":"Met endosomal signalling: In the right place, at the right time","volume":"49","author":"Barrow-McGee","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-018-0116-9","article-title":"Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1","volume":"8","author":"Chakraborty","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.xcrm.2025.102335_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105158","article-title":"Cleavage fragments of the C-terminal tail of polycystin-1 are regulated by oxidative stress and induce mitochondrial dysfunction","volume":"299","author":"Pellegrini","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102335_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.2018010039","article-title":"Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A","volume":"30","author":"Schreiber","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2025.102335_bib62","doi-asserted-by":"crossref","first-page":"26335","DOI":"10.1074\/jbc.M110.106435","article-title":"A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor","volume":"285","author":"Schelter","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102335_bib63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbrc.2007.12.177","article-title":"Caspase cleavage of the MET receptor generates an HGF interfering fragment","volume":"367","author":"Deheuninck","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102335_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.377","article-title":"Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity","volume":"4","author":"Lefebvre","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102335_bib65","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1128\/MCB.24.23.10328-10339.2004","article-title":"Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage","volume":"24","author":"Tulasne","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.981963","article-title":"Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xcrm.2025.102335_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081324","article-title":"Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases","volume":"11","author":"de Fays","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102335_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102974","article-title":"Lung immunoglobulin A immunity dysregulation in cystic fibrosis","volume":"60","author":"Collin","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2025.102335_bib69","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1083\/jcb.141.7.1503","article-title":"The SNARE Machinery Is Involved in Apical Plasma Membrane Trafficking in MDCK Cells","volume":"141","author":"Low","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib70","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0706578104","article-title":"Distinct pathways of genomic progression to benign and malignant tumors of the liver","volume":"104","author":"Tward","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102335_bib71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1083\/jcb.200309102","article-title":"Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture","volume":"165","author":"Wrobel","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102335_bib72","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2453","article-title":"Tracking Endocytosis and Intracellular Trafficking of Epitope-tagged Syntaxin 3 by Antibody Feeding in Live, Polarized MDCK Cells","volume":"8","author":"Giovannone","year":"2018","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.xcrm.2025.102335_bib73","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3049","article-title":"Transcytosis Assay for Transport of Glycosphingolipids across MDCK-II Cells","volume":"8","author":"Garcia-Castillo","year":"2018","journal-title":"Bio. Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:34:09Z","timestamp":1765888449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666379125004082"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102335","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a cyst-targeted therapy for polycystic kidney disease using an antagonistic dimeric IgA monoclonal antibody against cMET","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102335"}}